WVE Latest Headlines

Wave Life Sciences (WVE) Receives a Rating Update from a Top Analyst

at www.tipranks.com (Mon, 15-Dec 7:15 AM)

Wave Life Sciences (WVE) Receives a Buy from B. Riley Securities

at www.tipranks.com (Fri, 12-Dec 8:36 AM)

Wave Life Sciences Announces Public Offering for $402.5 Million

at www.tipranks.com (Thu, 11-Dec 6:30 AM)

Wave Life Sciences’ $350 Million Upsized Offering Highlights Expanding Investor Demand

Market Chameleon (Wed, 10-Dec 7:08 AM)

Wave Life Sciences prices upsized $350M stock offering

at seekingalpha.com (Wed, 10-Dec 1:53 AM)

Wave Life Science prices upsized $350M stock ofeering

at seekingalpha.com (Wed, 10-Dec 1:53 AM)

Wave Life Sciences Launches $250 Million Public Offering—How Could This Shape the Company’s Next Chapter?

Market Chameleon (Tue, 9-Dec 10:33 AM)

Wave Life Sciences Schedules INLIGHT Phase 1 Obesity Data Release—Could WVE-007 Redefine Metabolic Therapies?

Market Chameleon (Mon, 8-Dec 9:52 AM)

Wave Life Sciences Set to Release Interim Phase 1 INLIGHT Trial Data for Obesity Drug WVE-007—All Eyes on December 8

Market Chameleon (Mon, 8-Dec 7:08 AM)

Wave Life Sciences Schedules Q3 2025 Financial Results for November 10—Focus Remains on RNA Innovation

Market Chameleon (Tue, 4-Nov 9:26 AM)

WVE-007 Demonstrates Potent and Durable Fat Reduction in INLIGHT Trial, Paving the Way for Novel Obesity Therapies

Market Chameleon (Thu, 30-Oct 9:08 AM)